CEREBRAL ISCHAEMIA AFTER NIFEDIPINE TREATMENTNOBILE ORAZIO E; STERZI R.1981; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1981; VOL. 283; NO 6297; PP. 948; BIBL. 5 REF.Article

Intravenous immunoglobulin therapy in amyotrophic lateral sclerosisMEUCCI, N; NOBILE-ORAZIO, E; SCARLATO, G et al.Journal of neurology. 1996, Vol 243, Num 2, pp 117-120, issn 0340-5354Article

Gangliosides : their role in clinical neurologyNOBILE-ORAZIO, E; CARPO, M; SCARLATO, G et al.Drugs (Basel). 1994, Vol 47, Num 4, pp 576-585, issn 0012-6667Article

Treatment of chronic immune-mediated neuropathies: Impact of the Rare Diseases Centers network in ItalyNOBILE-ORAZIO, E.Revue neurologique (Paris). 2013, Vol 169, issn 0035-3787, S33-S38, SUP1Conference Paper

Anti-MAG antibody and antibody complexes: detection by radioimmunoassayNOBILE-ORAZIO, E; MCINTOSH, C; LATOV, N et al.Neurology. 1985, Vol 35, Num 7, pp 988-992, issn 0028-3878Article

Failure to detect anti-MAG antibodies by RIA in CSF of patients with multiple sclerosisNOBILE-ORAZIO, E; SPAGNOL, G; SCARLATO, G et al.Journal of neuroimmunology. 1986, Vol 11, Num 2, pp 165-169, issn 0165-5728Article

Anti-alpha- and beta-tubulin IgM antibodies in dysimmune neuropathiesMANFREDINI, E; NOBILE-ORAZIO, E; ALLARIA, S et al.Journal of the neurological sciences. 1995, Vol 133, Num 1-2, pp 79-84, issn 0022-510XArticle

Specificity of human IgM M-proteins that bind to myelin-associated glycoprotein: peptide mapping, deglycosylation, and competitive binding studiesSHY, M. E; VIETORISZ, T; NOBILE-ORAZIO, E et al.The Journal of immunology (1950). 1984, Vol 133, Num 5, pp 2509-2512, issn 0022-1767Article

Neuropathies associated with IgG and IgA monoclonal gammopathy : Médecine interne et maladies neurologiques = Internal medicine and neurological diseasesNOBILE-ORAZIO, E; CASELLATO, C; DI TROIA, A et al.Revue neurologique (Paris). 2002, Vol 158, Num 10, pp 979-987, issn 0035-3787, CAH1Conference Paper

Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a renal transplant recipientMACCARIO, M; TARANTINO, A; NOBILE-ORAZIO, E et al.Transplant international. 1998, Vol 11, Num 6, pp 439-442, issn 0934-0874Article

Marginally improved detection of GM1 antibodies by Covalink ELISA in multifocal motor neuropathyCARPO, M; ALLARIA, S; SCARLATO, G et al.Neurology. 1999, Vol 53, Num 9, pp 2206-2207, issn 0028-3878Article

Multifocal motor neuropathy : A source of error in the serial evaluation of conduction blockCAPPELLARI, A; NOBILE-ORAZIO, E; MEUCCI, N et al.Muscle & nerve. 1996, Vol 19, Num 5, pp 666-669, issn 0148-639XArticle

Long term disability and social status change after Guillain-Barré syndromeBERSANO, A; CARPO, M; ALLARIA, S et al.Journal of neurology. 2006, Vol 253, Num 2, pp 214-218, issn 0340-5354, 5 p.Article

Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathyMEUCCI, N; CAPPELLARI, A; BARBIERI, S et al.Journal of neurology, neurosurgery and psychiatry. 1997, Vol 63, Num 6, pp 765-769, issn 0022-3050Article

High-dose intravenous immunoglobulin therapy in multifocal motor neuropathyNOBILE-ORAZIO, E; MEUCCI, N; BARBIERI, S et al.Neurology. 1993, Vol 43, Num 3, pp 537-544, issn 0028-3878, 1Article

Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapyODAKA, M; YUKI, N; NOBILE-ORAZIO, E et al.Journal of the neurological sciences. 2000, Vol 175, Num 2, pp 96-106, issn 0022-510XArticle

Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapiesNOBILE-ORAZIO, E; MEUCCI, N; BALDINI, L et al.Brain. 2000, Vol 123, pp 710-717, issn 0006-8950, 4Article

Visual evoked potentials in patients with neuropathy and macroglobulinemiaBARBIERI, S; NOBILE-ORAZIO, E; BALDINI, L et al.Annals of neurology. 1987, Vol 22, Num 5, pp 663-666, issn 0364-5134Article

SERUM VEGF LEVELS IN POEMS SYNDROME AND IN IMMUNE-MEDIATED NEUROPATHIESNOBILE-ORAZIO, E; TERENGHI, F; GIANNOTTA, C et al.Neurology. 2009, Vol 72, Num 11, pp 1024-1026, issn 0028-3878, 3 p.Article

Low-grade non-Hodgkin B-cell lymphoma presenting as sensory neuropathyGEMIGNANI, F; MARCHESI, G; DI GIOVANNI, G et al.European neurology. 1996, Vol 36, Num 3, pp 138-141, issn 0014-3022Article

How long is IVIg effective in multifocal motor neuropathy?TERENGHI, F; CAPPELLARI, A; BERSANO, A et al.Neurology. 2004, Vol 62, Num 4, pp 666-668, issn 0028-3878, 3 p.Article

Anti-GM₁ IgM antibodies in motor neuron disease and neuropathyNOBILE-ORAZIO, E; CARPO, M; LEGNAME, G et al.Neurology. 1990, Vol 40, Num 11, pp 1747-1750, issn 0028-3878, 4 p.Article

Expression of glycosylated recombinant human myelin-associated glycoprotein on a neuroblastoma cell line and its reactivity with HNK-1 but not human anti-MAG antibodiesSPAGNOL, G; DONEDA, P; CAVANNA, B et al.Neuroscience letters. 1998, Vol 246, Num 3, pp 157-160, issn 0304-3940Article

Antisulfatide polyneuropathy : antibody-mediated complement attack on peripheral myelinFERRARI, S; MORBIN, M; NOBILE-ORAZIO, E et al.Acta neuropathologica. 1998, Vol 96, Num 6, pp 569-574, issn 0001-6322Article

Criteria for early detection of conduction block in multifocal motor neuropathy (MMN) : a study based on control populations and follow-up of MMN patientsCAPPELLARI, A; NOBILE-ORAZIO, E; MEUCCI, N et al.Journal of neurology. 1997, Vol 244, Num 10, pp 625-630, issn 0340-5354Article